Skip to content

Effect of a Home-based Electrical Stimulation on Quadriceps Function After Knee Surgery

Effects of a Superimposed Electrical Stimulation Knee Garment on Strength, Function, Inhibition, Cortical Excitability, and Patient Reported Outcomes After Knee Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02058862
Enrollment
87
Registered
2014-02-10
Start date
2014-05-31
Completion date
2018-10-31
Last updated
2018-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adherence to Post-operative Treatment, Post-operative Lower Extremity Function, Post-operative Quadriceps Inhibition, Post-operative Quadriceps Weakness

Brief summary

The purpose of this study is to determine if a home-based electrical stimulation (ES) program is more effective than the standard of care (SOC) at improving quadriceps function, functional outcomes, patient reported outcomes, and treatment compliance in patients recovering from knee surgery. It is hypothesized that there will be significantly better outcomes and compliance in ES group when compared to the SOC group.

Detailed description

The purpose of this study is to evaluate the effect of home-based neuromuscular electrical stimulation applied via a knee sleeve on strength, function, inhibition, and patient reported outcomes. Strength will be evaluated via isometric knee extension, neuromuscular inhibition will be assessed via a superimposed burst technique, and cortical excitability will be assessed via transcranial magnetic stimulation. In addition, we will evaluate function through a single-leg hop task, star excursion balance test, and a step down task. Patient reported outcomes will be assessed via the: Veterans Rand 12 Item Health Survey (VR-12), Knee Osteoarthritis Outcomes Score (KOOS), the International Cartilage Repair Society (ICRS), the International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form, and the Lysholm scale. Once a participant is identified as eligible and consents to enroll in the study, they will be allocated to either an intervention or control group. The participants in the intervention group will receive a knee sleeve that has a neuromuscular ES unit embedded into the garment (EMPI Phoenix, DJO Global, Vista, California) in addition to SOC. A superimposed electrical signal (maximal toleration) will be utilized during treatment in order to successfully overload the muscle. During the electrical stimulation the participants will be instructed to perform an isometric contraction and hold this contraction through the length of the stimulation. Beginning one week post-operatively the participants will be instructed to perform NMES treatment 3 times a day for 20 minutes 5 times a week for 12 weeks. The stimulation will be delivered at a frequency of 75Hz with a duty cycle of 4 seconds on and 10 seconds off. The control group will be treated with the current SOC, performing a home-based treatment of volitional isometrics contractions without the addition of neuromuscular electrical stimulation beginning on the third day post-operatively. Participants will perform 20 isometric contractions holding each contraction for 10 seconds 3 times a day 5 times a week for 12 weeks. Participants will be instructed to keep a treatment log documenting at each session how many exercises and at what intensity they performed.

Interventions

None listed

Sponsors

DonJoy Orthopedics
CollaboratorUNKNOWN
University of Kentucky
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
12 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Must be scheduled for surgery to address pain, injury, or dysfunction of the knee joint. * Must be able to communicate using the English language

Exclusion criteria

* Previous surgery to the contralateral ankle, hip, or knee * Injury to the hip, ankle, or contralateral knee in the past six months * Currently being treated for low back pain * Presence of a heart condition/pacemaker * History and/or family history of seizures/epilepsy * Vestibular or other balance disorders

Design outcomes

Primary

MeasureTime frameDescription
Isometric knee extension torquePreoperative baseline, 1 month post-operative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operativeKnee extension torque derived from a maximal voluntary isometric contraction
Quadriceps activationPreoperative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operativeCentral activation ratio of the quadriceps derived from the superimposed burst technique

Secondary

MeasureTime frameDescription
Patient-reported outcomesPreoperative, 1 month post-operative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operativePatient-reported outcome measures will include the following: Veterans Rand 12 Item Health Survey (VR-12), Knee Osteoarthritis Outcomes Score (KOOS), the International Cartilage Repair Society (ICRS), the International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form, and the Lysholm scale
Functional outcomesPreoperative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operativeFunctional outcome measures will include the following: Single-leg hop, 30-second step down, and star-excursion balance test.
Cortical excitabilityPreoperative, 1 month post-operative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operativeIndividuals who have been diagnosed with epilepsy or have a family history of epilepsy may be at risk of seizure during cortical excitability testing. Therefore, these individuals will be excluded from this study. Otherwise, this measure is considered to be safe and is used in the realms of both medicine and research.

Other

MeasureTime frameDescription
Treatment compliancePreoperative, 1 month post-operative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operativeThe number and duration of treatments performed by the patients

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026